# A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer

> **NCT01351597** · PHASE2 · UNKNOWN · sponsor: **Korean Breast Cancer Study Group** · enrollment: 51 (estimated)

## Conditions studied

- Recurrent Breast Cancer
- Metastatic Breast Cancer

## Interventions

- **DRUG:** docetaxel/ oxaliplatin

## Key facts

- **NCT ID:** NCT01351597
- **Lead sponsor:** Korean Breast Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-09
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2011-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351597, "A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01351597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*